Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Association of Chronic Covert Cerebral Infarctions and White Matter Hyperintensities With Atrial Fibrillation Detection on Post‐Stroke Cardiac Rhythm Monitoring: A Cohort Study

Autor: Ulfrid Amberger, Julian Lippert, Adnan Mujanovic, Morin Beyeler, Bernhard Siepen, Jan Vynckier, Adrian Scutelnic, Martina Goeldlin, David Seiffge, Simon Jung, Jan Gralla, Marcel Arnold, Johannes Kaesmacher, Tobias Reichlin, Hildegard Tanner, Urs Fischer, Laurent Roten, Thomas Raphael Meinel

Publikováno v: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 11, Iss 24 (2022)

Background This study was conducted to explore the association of different phenotypes, count, and location of chronic covert brain infarctions (CBIs) with detection of atrial fibrillation (AF) on prolonged post‐stroke cardiac rhythm monitoring (PC

Externí odkaz: https://doaj.org/article/258f1644dc9c4ba4a9d03e104e58ec11

Systematic Review on the Cost Effectiveness of Prostate Cancer Screening in Europe.

Autor: Vynckier P; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium. Electronic address: pieter.vynckier@ugent.be., Annemans L; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium., Raes S; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium., Amrouch C; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium; Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium., Lindgren P; Swedish Institute for Health Economics, Lund, Sweden., Májek O; National Screening Centre, Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia., Beyer K; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Leenen RCA; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Venderbos LDF; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Denijs F; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., van Harten MJ; Cancer Center, Department of Urology, University Medical Center Utrecht, Utrecht, The Netherlands., Helleman J; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands., Chloupková R; National Screening Centre, Institute of Health Information and Statistics of the Czech Republic, Prague, Czechia; Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University, Brno, Czechia., Briers E; Europa Uomo, Antwerp, Belgium., Vasilyeva V; European Association of Urology, Policy Office, Arnhem, The Netherlands., Rivas JG; Department of Urology, Clínico San Carlos University Hospital, Madrid, Spain., Basu P; International Agency for Research on Cancer/World Health Organization, Lyon, France., Chandran A; International Agency for Research on Cancer/World Health Organization, Lyon, France., van den Bergh RCN; Department of Urology, Sint Antonius Hospital, Utrecht-Nieuwegein, The Netherlands., Collen S; European Association of Urology, Policy Office, Arnhem, The Netherlands., Van Poppel H; European Association of Urology, Policy Office, Arnhem, The Netherlands; Department of Urology, KU Leuven, Leuven, Belgium., Roobol MJ; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center Rotterdam, The Netherlands.

Publikováno v: European urology [Eur Urol] 2024 Nov; Vol. 86 (5), pp. 400-408. Date of Electronic Publication: 2024 May 23.

Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveys

Autor: Giulia Ferrannini, Dirk De Bacquer, Pieter Vynckier, Guy De Backer, Viveca Gyberg, Kornelia Kotseva, Linda Mellbin, Anna Norhammar, Jaakko Tuomilehto, David Wood, Lars Rydén, EUROASPIRE IV & V Investigators

Publikováno v: Cardiovascular Diabetology, Vol 20, Iss 1, Pp 1-12 (2021)

Abstract Background Gender disparities in the management of dysglycaemia, defined as either impaired glucose tolerance (IGT) or type 2 diabetes (T2DM), in coronary artery disease (CAD) patients are a medical challenge. Recent data from two nationwide

Externí odkaz: https://doaj.org/article/0348029b0ef54ed2ab14d6064ea94aad